Atlas Trials

Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Clinical trial NCT05768503 · RECRUITING

Trial details

NCT number
NCT05768503
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Microsatellite-stable Colorectal Cancer
Start date
2023-03-01
Primary completion
2026-01-01
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.